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LETTERS TO THE EDITOR
Response to the Article
“Pulmonary Resection
for Metastatic Gastric
Cancer” by Kemp et al.
To the Editor:
Searching the literature, Kemp et
al.1 found clinical reports on only 43
individuals who had surgical excision of
one or more pulmonary metastasis for
gastric cancer. On the basis of the data
extracted, the authors suggest that this
surgery should be considered for future
patients. A cautionary note is that 12 of
21 publications included in the review
were of single case reports; the median
number of cases per report is thus 1.
Case reports appear in journals primar-
ily because they are outside the norm
and unrepresentative of the usual course
of events.
The vital question is how would
patients such as these have fared were it
not for the metastasectomy; the authors
implicitly offer 2% survival as the com-
parator. Their source2 applies to patients
who had distant metastases at the time of
entry to the National Cancer Database
and are quite unlike those in Kemp’s
report where 33 of 34 patients were free
of any metastases at the time of gastrec-
tomy. Apparently 79% of patients with
metastatic disease from gastric cancer
present within 2 years of gastric resec-
tion, but the interval between gastrec-
tomy and metastasectomy was nearly 3
years in Kemp’s report. Of the 42 indi-
viduals where the pulmonary metastasis
count is provided, 34 (81%) had a single
metastasis, which is not the typical pat-
tern of metastatic disease. Is it likely that
these very few atypical cases reported
over more than 30 years, 41 of 43 from
Japan, inform practice in a disease that
kills 10,000 a year in the United States?
Parallels are drawn with pulmo-
nary metastasectomy for colorectal can-
cer.1 The conclusion of a 2010 system-
atic review reads “outcomes exceed
those normally associated with meta-
static colorectal cancer. It is this percep-
tion that has encouraged surgeons and
caused the practice to grow.”3 This is a
more tentative conclusion than Kemp et
al. suggest. Five-year survival after pul-
monary metastasectomy in colorectal
cancer has been consistently of the order
of 40% over 40 years.4 Is this a conse-
quence of surgery or selection? The
proposition put in 1980 is unresolved
after 30 years.5 To test the hypothesis,
data on Dukes stage and “disease-free
interval” from American and Japanese
reports of 144 and 159 patients6,7 were
used to construct a model among pa-
tients matched for these factors in the
Thames Cancer Registry. The model
predicted similar survival to that ob-
served, making selection the likely de-
terminant.8 (A more readily accessible
summary account is in the article by
Utley and Treasure in the journal.)9
The practice of metastasectomy is
extremely variable and increasing10 and
is without a secure evidence base.11
There is sufficient doubt about the value
of pulmonary metastasectomy for colo-
rectal cancer for a multicenter, random-
ized, controlled trial to have been set
up.12,13 What is seen in colorectal cancer
might also apply in gastric cancer, but
given the doubts about the present evi-
dence, it would be prudent to not extrap-
olate to gastric carcinoma but to seek
better evidence.
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In Response:
I enjoyed reading the authors’ com-
ments. At the time of writing the original
article, we found ourselves asking the ex-
act same questions. We completely agree
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